Publications

Found 6 results
Filters: Keyword is Tissue Distribution and Author is S Muyldermans  [Clear All Filters]
2012
D'huyvetter, M., A. Aerts, C. Xavier, I. Vaneycken, N. Devoogdt, M. Gijs, N. Impens, S. Baatout, B. Ponsard, S. Muyldermans, et al., "Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.", Contrast Media Mol Imaging, vol. 7, issue 2, pp. 254-64, 2012 Mar-Apr.
Hmila, I., B. Cosyns, H. Tounsi, B. Roosens, V. Caveliers, R. Ben Abderrazek, S. Boubaker, S. Muyldermans, M. El Ayeb, B. Bouhaouala-Zahar, et al., "Pre-clinical studies of toxin-specific nanobodies: evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming.", Toxicol Appl Pharmacol, vol. 264, issue 2, pp. 222-31, 2012 Oct 15.
2011
Vaneycken, I., N. Devoogdt, N. Van Gassen, C. Vincke, C. Xavier, U. Wernery, S. Muyldermans, T. Lahoutte, and V. Caveliers, "Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.", FASEB J, vol. 25, issue 7, pp. 2433-46, 2011 Jul.
2010
Vaneycken, I., J. Govaert, C. Vincke, V. Caveliers, T. Lahoutte, P. De Baetselier, G. Raes, A. Bossuyt, S. Muyldermans, and N. Devoogdt, "In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.", J Nucl Med, vol. 51, issue 7, pp. 1099-106, 2010 Jul.
De Groeve, K., N. Deschacht, C. De Koninck, V. Caveliers, T. Lahoutte, N. Devoogdt, S. Muyldermans, P. De Baetselier, and G. Raes, "Nanobodies as tools for in vivo imaging of specific immune cell types.", J Nucl Med, vol. 51, issue 5, pp. 782-9, 2010 May.
2004
Cortez-Retamozo, V., N. Backmann, P. D. Senter, U. Wernery, P. De Baetselier, S. Muyldermans, and H. Revets, "Efficient cancer therapy with a nanobody-based conjugate.", Cancer Res, vol. 64, issue 8, pp. 2853-7, 2004 Apr 15.